• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events

25th LEAP Platform Meeting

3-4 October 2018

Kampala, Uganda

The theme of the 25th LEAP Platform Meeting is “Improving Access to Treatments for Leishmaniasis Patients through Partnerships“.

Opening session

Date: Wednesday, 3 October 2018
Time: 8:30-9:00

Welcome and introductionJoseph Olobo, Makerere University, Uganda
Introductory remarksAsrat Hailu, Addis Ababa University, Ethiopia
Monique Wassuna, Director, DNDi Africa, Kenya
Bernard Pécoul, Executive Director, DNDi, Switzerland

 

Sessions

LEAP@15 – The past, the present & the future

Time: 9:00-10:40

Chairs: Eltahir Khalil Gasim, Institute of Endemic Diseases (IEND), University of Khartoum, Sudan & Nathalie Strub-Wourgaft, NTD Director, DNDi, Switzerland

History of LEAP
Monique Wassuna, Director, DNDi Africa, Kenya
Current situation: Leish in Africa
Eltahir Khalil Gasim, Institute of Endemic Diseases (IEND), University of Khartoum, Sudan
DNDi strategy for visceral leishmaniasis
Fabiana Alves, Head of Visceral Leishmaniasis Clinical Programme, DNDi, Switzerland
New Chemical Entities: Overview of the NCEs portfolio development
Charles Mowbray, Discovery Director, DNDi, Switzerland

 

Translating evidence into policy

Time: 11:00-13:00

Chairs: Alfred Mubangizi & Nathalie Strub-Wourgaft, NTD Director, DNDi, Switzerland

HIV/VL situation in Ethiopia
Asrat Hailu, Addis Ababa University, Ethiopia
Access to leishmaniasis treatment in Africa: WHO perspective
José Ruiz Postigo, World Health Organization (WHO), Switzerland
Regulatory issues: Situational overview of regulatory harmonization in Africa
Margareth Ndomondo-Sigonda, NEPAD, South Africa
Quality of ethics review and harmonization
Stephen K. Karimi, National Council for Science & Technology (NACOSTI), Kenya
Access and advocacy: Access to VL treatment in eastern Africa: KalaCORE’s experience–what we need to know
Duncan Ochol, IMA World Health, South Sudan
Respondent: Yibeltal Abeje Melese, EFMHACA, Ethiopia

 

Country Updates

Time: 14:00-16:00

Chairs: Eyasu Mekonnen, College of Health Sciences, Addis Ababa University, Ethiopia & Jane Mbui, Kenya Medical Research Institute (KEMRI), Kenya

Overview of VL activities in Ethiopia
Asrat Hailu, Addis Ababa University, Ethiopia
Overview of VL activities in Kenya
Jane Mbui, Kenya Medical Research Institute (KEMRI), Kenya
Overview of VL activities in Sudan
Ahmed Musa Mudawi, Institute of Endemic Diseases (IEND), University of Khartoum, Sudan
Overview of VL activities in Uganda
Joseph Olobo, Makerere University, Uganda
Overview of VL activities in South Sudan
Lexson Mabrouk Madibe, Ministry of Health, South Sudan
Overview of VL activities in Somalia
Mohammed Fuje, WHO, Somalia
Mycetoma in Sudan
Ahmed Fahal, Mycetoma Research Centre, University of Khartoum, Sudan

 

AfriKADIA Project

Time: 16:00-17:00

Chairs: Fabiana Alves, Head of Visceral Leishmaniasis Clinical Programme, DNDi, Switzerland & Jorge Alvar, Senior Leishmaniasis Advisor, DNDi, Switzerland

EDCTP/Afri-KA-DIA Project overview (including WP4)
Jorge Alvar, Senior Leishmaniasis Advisor, DNDi, Switzerland
WP1 – PM/MF Clinical Trial
Ahmed Musa Mudawi, Institute of Endemic Diseases (IEND), University of Khartoum, Sudan
WP2 – Diagnostic
Isra Cruz, FIND, Switzerland
WP3 – Capacity Building
Joy Malongo, LEAP/EU FP7 Coordinator, DNDi Africa, Kenya

 

PKDL

Date: Thursday, 4 October 2018
Time: 8:00-9:10

Chairs: Jorge Alvar, Senior Leishmaniasis Advisor, DNDi, Switzerland & Ed Zijlstra, Senior Consultant, DNDi

PKDL in Asia – the context of VL Elimination programme and the role of PKDL in transmission
Jorge Alvar, Senior Leishmaniasis Advisor, DNDi, Switzerland
PKDL in Sudan
Brima Younis, Institute of Endemic Diseases (IEND), University of Khartoum, Sudan
Leishmania vaccine candidate ChAd63-KH – initial results and development plan
Ahmed Musa Mudawi, Institute of Endemic Diseases (IEND), University of Khartoum, Sudan
PKDL Target Product Profile
Fabiana Alves, Head of Visceral Leishmaniasis Clinical Programme, DNDi, Switzerland

 

Capacity strengthening

Time: 9:30-10:30

Chairs: Yalemtsehay Mekonnen, College of Natural Sciences, Addis Ababa University, Ethiopia

Update on the IDDO VL Data Sharing Platform
Michael Ochieng, Information Systems Manager, DNDi Africa, Kenya
DC After 14 Years: Challenges and Opportunities
Raymond Omollo, Head of Data Center, DNDi Africa, Kenya
Standardization of GFP
Simon Bolo, Regional Operations Leader, DNDi Africa, Kenya
2nd LEAP Scientific Conference – formation of working groups
Jorge Alvar, Senior Leishmaniasis Advisor, DNDi, Switzerland
Monique Wassuna, Director, DNDi Africa, Kenya
Way forward, action points and wrap up of meeting
Joy Malongo, LEAP/EU FP7 Coordinator, DNDi Africa, Kenya
Close meeting
Asrat Hailu, Addis Ababa University, Ethiopia
Joseph Olobo, Makerere University, Uganda
Monique Wassuna, Director, DNDi Africa, Kenya

More information:

  • Full programme

Other events

Loading...
15-20 June 2025

Kigali, Rwanda

Twelfth EDCTP Forum

15-18 June 2025

Manila, Philippines

8th Asia Dengue Summit

22 May 2025

Online event

MSF Scientific Days

21 May 2025, 9-10:30 AM

Geneva, Switzerland

Scaling impact: Climate & health solutions that drive change

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License